Detalhe da pesquisa
1.
Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19).
Clin Infect Dis
; 76(3): e26-e33, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031408
2.
Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD.
Eur Respir J
; 61(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926878
3.
Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19.
Brief Bioinform
; 22(2): 1466-1475, 2021 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620066
4.
Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates.
Respirology
; 28(1): 47-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36065624
5.
Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life.
BMC Pulm Med
; 23(1): 441, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964259
6.
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.
Gut
; 71(3): 544-552, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082169
7.
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19.
Hepatology
; 74(4): 1750-1765, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961298
8.
Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019.
J Am Soc Nephrol
; 32(4): 961-971, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483314
9.
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Gut
; 70(4): 733-742, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641471
10.
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Gut
; 70(4): 698-706, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431578
11.
Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study.
Clin Infect Dis
; 72(10): e466-e475, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33005933
12.
Epidemiology, clinical spectrum, viral kinetics and impact of COVID-19 in the Asia-Pacific region.
Respirology
; 26(4): 322-333, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690946
13.
Effect of short-course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial.
Respirology
; 26(1): 72-79, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542906
14.
Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study.
J Med Internet Res
; 23(4): e26645, 2021 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750740
15.
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD.
Eur Respir J
; 56(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32341102
16.
Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
Gastroenterology
; 164(1): 151-153, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126688
17.
Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
Respir Res
; 20(1): 210, 2019 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519188
18.
GOLD 2023 executive summary: comments from Asia's perspective.
Eur Respir J
; 61(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321617
19.
IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 Influenza.
J Infect Dis
; 216(1): 97-104, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28510725
20.
Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?
Respirology
; 27(12): 1006-1007, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031687